Dr. Melissa A Reimers, M.D.
Claim this profileWashington University School of Medicine
Area of expertise
Kidney Cancer
Melissa A Reimers, M.D. has run 7 trials for Kidney Cancer. Some of their research focus areas include:
Bladder Cancer
Melissa A Reimers, M.D. has run 6 trials for Bladder Cancer. Some of their research focus areas include:
Affiliated Hospitals
Washington University School Of Medicine
Siteman Cancer Center-South County
Clinical Trials Melissa A Reimers, M.D. is currently running
Personalized Cancer Vaccine
for Bladder Cancer
This is a phase 1 clinical trial to evaluate the safety, feasibility and immunogenicity of a personalized cancer vaccine strategy in patients with solid tumors and molecular residual disease. The hypothesis of the trial is that synthetic long peptide personalized cancer vaccines will be safe and capable of generating measurable neoantigen-specific T-cell responses enabling ctDNA clearance. The personalized cancer vaccines are composed of synthetic long peptides corresponding to prioritized cancer neoantigens and will be co-administered with poly-ICLC.
Recruiting
1 award
Phase 1
7 criteria
Tivozanib + Pembrolizumab
for Kidney Cancer
This phase III trial compares the effect of adding tivozanib to standard therapy pembrolizumab versus pembrolizumab alone for the treatment of patients with high-risk renal cell carcinoma (RCC). Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Tivozanib is in a class of medications called kinase inhibitors. It works by blocking the action of the abnormal protein that signals tumor cells to multiply. This helps stop the spread of tumor cells. Giving pembrolizumab and tivozanib together may work better than pembrolizumab alone in treating patients with RCC.
Recruiting
2 awards
Phase 3
7 criteria
More about Melissa A Reimers, M.D.
Clinical Trial Related
6 years of experience running clinical trials · Led 16 trials as a Principal Investigator · 3 Active Clinical Trials
Treatments Melissa A Reimers, M.D. has experience with
- Nivolumab
- Cabozantinib
- Pembrolizumab
- Atezolizumab
- Ipilimumab
- Avelumab
Breakdown of trials Melissa A Reimers, M.D. has run
Kidney Cancer
Bladder Cancer
Prostate Cancer
Urothelial Bladder Cancer, Breast Cancer, Pancreatic Adenocarcinoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Melissa A Reimers, M.D. specialize in?
Melissa A Reimers, M.D. focuses on Kidney Cancer and Bladder Cancer. In particular, much of their work with Kidney Cancer has involved Stage IV patients, or patients who are Stage III.
Is Melissa A Reimers, M.D. currently recruiting for clinical trials?
Yes, Melissa A Reimers, M.D. is currently recruiting for 3 clinical trials in Saint Louis Missouri. If you're interested in participating, you should apply.
Are there any treatments that Melissa A Reimers, M.D. has studied deeply?
Yes, Melissa A Reimers, M.D. has studied treatments such as Nivolumab, Cabozantinib, Pembrolizumab.
What is the best way to schedule an appointment with Melissa A Reimers, M.D.?
Apply for one of the trials that Melissa A Reimers, M.D. is conducting.
What is the office address of Melissa A Reimers, M.D.?
The office of Melissa A Reimers, M.D. is located at: Washington University School of Medicine, Saint Louis, Missouri 63110 United States. This is the address for their practice at the Washington University School of Medicine.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.